Cannabis and Rescheduling to Schedule III! Podcast Por  capa

Cannabis and Rescheduling to Schedule III!

Cannabis and Rescheduling to Schedule III!

Ouça grátis

Ver detalhes do programa

Sobre este áudio

Cannabis and Rescheduling to Schedule III

In this week’s episode, Ryan dives into the hot topic of cannabis rescheduling and breaks down what it really means for patients, businesses, and people in prohibition states. He explains how the Controlled Substances Act works, the differences between Schedule 1, 2, and 3, and why moving cannabis to Schedule 3 could be one of the most significant federal shifts in decades. From potential research expansion, tax relief, and improved banking access to increased patient trust, better medical options, and possible insurance coverage, Ryan explores the many ways this change could shape the future of cannabis. He also covers what would not change, the impact on restrictive states, and the risks and limitations that come with rescheduling, giving listeners a clear and balanced view of what lies ahead.

References

https://www.reuters.com/world/us/how-us-marijuana-reclassification-could-help-cannabis-companies-2025-08-12

What Does Schedule III Mean for Me? - Michael Best & Friedrich LLP

https://www.pillsburylaw.com/en/news-and-insights/doj-rescheduling-marijuana.html

Info:

Cannabis Connoisseur Podcast Info:

Follow us @ThecannabisC on instagram

E-mail us at: thecannabisc@gmail.com

Youtube: https://www.youtube.com/watch?v=7BRwpUrBgQM&t=5s

“Disclaimer: The content provided in this podcast is for informational purposes only and should Not be considered medical advice. The hosts and guests are not medical professionals, and their opinions are based on personal research and experiences. It is always recommended to consult with a qualified healthcare professional before making any medical decisions or changes to your treatment plan. This podcast does not endorse or promote the use of cannabis for medical purposes without the supervision of a licensed healthcare provider.

Ainda não há avaliações